Expand

The Brief

Moderna's new option is a lower-dose version that is a step toward next-generation coronavirus vaccines.

It’s called mNexspike.

Moderna’s new COVID-19 vaccine is recommended as another option but not a replacement for their current vaccine.

The Food and Drug Administration approved Moderna’s new lower-dose COVID-19 vaccine over the weekend.

The FDA stressed that this is not considered a replacement for the company’s existing shot but can be considered as a second option.

mNexspike

Dig deeper:

Moderna’s new COVID-19 vaccine, named mNexspike, is a fifth of the dose of its current COVID-19 vaccine, Spikevax.

It is considered a step toward next-generation coronavirus vaccines.

mNexspike is approved for use in all adults 65 and older and for people aged 12 to 64 wi

See Full Page